IMW 2019 | MRD negativity in myeloma patients undergoing maintenance therapy

Benjamin Derman

Benjamin Derman, MD, from the University of Chicago, Chicago, IL, talks about how MRD can be best utilized in the near future. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  
Similar topics